Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 31 Aug 2017 Last checked against ClinicalTrials.gov record.
- 25 Feb 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 25 Feb 2011 Planned end date changed from 1 Feb 2012 to 1 Feb 2011 as reported by ClinicalTrials.gov.